Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
„Aprangos“ grupės (toliau - Grupė) tinklo mažmeninė prekių apyvarta (su PVM) per 2025 m. 12 mėnesių sudarė 371,7 mln. eurų, arba 4,9% daugiau nei atitinkamu praeitų metų laikotarpiu. Grupės...
-
The retail turnover (including VAT) of Apranga Group reached EUR 371.7 million in 12 months 2025 and increased by 4.9% year-on-year. The unaudited consolidated profit before income tax of Apranga...
-
Biologic Innovation to Drive Global Ophthalmic Drugs Market Growth at 7.9% CAGR Through 2036, supported by anti-VEGF therapies and AI-enabled imaging.
-
Pixalate's free KYD database exposes child privacy risks from 356K mobile app developers after Apple/Google fail.
-
NEW YORK , Feb. 03, 2026 (GLOBE NEWSWIRE) -- Intezer, the AI SOC platform for enterprise powered by ForensicAI™, today released its 2026 AI SOC Report for CISOs, based on the forensic analysis of...
-
MONTRÉAL, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Genetec Inc. (“Genetec”), the global leader in enterprise physical security software, today released healthcare-specific insights from its 2026 State...
-
Highlights New permanent Category I CPT code 75577 for AI-enabled coronary plaque analysis took effect January 1, 2026Major payers, including Aetna, alongside UnitedHealthcare, Cigna, Humana, and...
-
Tiziana reports excellent safety profile with intranasal foralumab after 37.4 patient-years cumulative exposureFDA denial of Sanofi’s tolebrutinib for nrSPMS shows need for safe therapy BOSTON, Dec. ...
-
The FSR Voice of the Patient report outlines a clear path forward for drug developers, researchers, clinicians, and regulators for sarcoidosis.
-
BOISE, Idaho, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced results for its first quarter of fiscal 2026, which ended November 27, 2025. Fiscal Q1 2026...